Hikma Pharmaceuticals

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.

Contact Details

Address: 13 Hanover Square, London, United Kingdom

Phone: +44 (0)20 7399 2760

Fax: +44 (0)20 7399 2761

Website: http://www.hikma.com

Related news from City A.M.

Easyjet and Marks and Spencer candidates for relegation in FTSE reshuffle
Easyjet and Marks and Spencer candidates for relegation in FTSE reshuffle
Easyjet looks set to be the next company to fall out of the FTSE 100, with several others, including Marks [...]
June 2, 2019
Best 25 stocks in the last tax year
Best 25 stocks in the last tax year
By Graeme Evans from interactive investor. The FTSE 100 outperformed mid-caps last tax year, but the top FTSE 350 performers [...]
April 15, 2019
City Moves for 5 October 2018 – who’s switching jobs at Hikma Pharmaceuticals, Evestment, Nucleus and City AM?
City Moves for 5 October 2018 – who’s switching jobs at Hikma Pharmaceuticals, Evestment, Nucleus and City AM?
Today's City Moves covers pharma, investment, IT and City Moves. Take a look at these movers and shakers: Hikma Pharmaceuticals [...]
October 5, 2018
FTSE 100 and 250 quarterly review takes effect as Hikma, Tullow Oil and Afren shuffle
FTSE 100 and 250 quarterly review takes effect as Hikma, Tullow Oil and Afren shuffle
The shake-up revealed as a result of the quarterly review of the FTSE 100 and 250 takes effect this morning.Hikma Pharmaceuticals [...]
March 23, 2015
FTSE 100 and 250 promotions and relegations: Tullow Oil, Afren set to slip after quarterly review
FTSE 100 and 250 promotions and relegations: Tullow Oil, Afren set to slip after quarterly review
Tullow Oil and Afren are likely to slip out of their respective FTSE indexes after this week's quarterly review.Analysis by [...]
March 2, 2015

Content tagged with "Hikma Pharmaceuticals"